Strategic Growth and Support for the Pancreatic Cancer Action Network's Research Agenda

Lynn Matrisian (Chief Science Officer) and Julie Fleshman (President & CEO) of the Pancreatic Cancer Action Network (PanCAN) share the strategic evolution of PanCAN's research program from individual grants to multi-institutional clinical trial consortia. A focus will be on the concomitant requirement for organizational infrastructure changes to manage and support multi-year and multi-million dollar initiatives.

Видео Strategic Growth and Support for the Pancreatic Cancer Action Network's Research Agenda канала Genetic Alliance